AstraZeneca Q1: Tagrisso Beats Expectations And Drives Oncology Performance

 
• By Lucie Ellis-Taitt

Tagrisso shines for AstraZeneca in the first quarter and the company is on track for approval of a fifth new cancer drug, in line with 2014 promises made by CEO Pascal Soriot when the company rejected takeover offers from Pfizer.

Sun rays
Oncology portfolio shines for AstraZeneca in Q1 despite financial performance pressures • Source: Shutterstock

More from Earnings

More from Business